You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,939,502


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,939,502
Title:Optimised formulation of tobramycin for aerosolization
Abstract: The invention provides a tobramycin formulation for delivery by aerosolization in the form of additive-free, isotonic solution whose pH has been optimised to ensure adequate shelf-life at room temperature. Said formulation can be advantageously used for the treatment and prophylaxis of acute and chronic endobronchial infections, in particular those caused by the bacterium Pseudomonas aeruginosa associated to lung diseases such as cystic fibrosis.
Inventor(s): Malvolti; Chiara (Parma, IT), Garzia; Raffaella (Parma, IT)
Assignee: Chiesi Farmaceutici S.p.A. (Parma, IT)
Application Number:12/642,336
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,939,502
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,939,502: A Comprehensive Analysis

Introduction

Patent 7,939,502, like any other patent, is a complex document that outlines the invention, its scope, and the claims that define the intellectual property protected by the patent. This analysis will delve into the key components of this patent, including its background, summary, detailed description, and claims.

Background of Patent 7,939,502

To begin with, it is essential to understand the context in which the patent was filed and granted. This involves looking at the prior art, the problems the invention aims to solve, and the relevant technical field.

Prior Art and Technical Field

The prior art section of the patent typically discusses existing technologies and inventions that are related to the current invention. This helps in understanding how the new invention improves upon or differs from what already exists in the field[2].

Problems Addressed

The background section often highlights the specific problems or limitations of existing technologies that the new invention addresses. This provides a clear rationale for why the invention was necessary and how it contributes to the advancement of the field.

Summary of the Invention

The summary section provides a concise overview of the invention, including its main features and how it operates. This section is crucial for quickly understanding the essence of the patent.

Key Features

  • Inventive Concept: This includes the core idea or principle behind the invention.
  • Novelty and Nonobviousness: The summary should indicate how the invention is novel and nonobvious over the prior art, which are critical criteria for patentability[2].

Detailed Description of the Invention

This section provides a detailed explanation of the invention, including drawings, diagrams, and detailed descriptions of each component.

Components and Their Functions

  • Each component of the invention is described in detail, along with its function and how it interacts with other components.
  • This section may also include examples or embodiments of the invention to illustrate its application[2].

Claims of the Patent

The claims are the most critical part of a patent as they define the scope of the invention and what is protected by the patent.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims, often adding additional features or details[3].

Claim Construction

The claims are written in a specific legal language and must be clear and definite. The construction of claims involves interpreting the language used to determine the scope of protection.

Examples from Patent 7,939,502

To illustrate, let's consider an example from the claims section of Patent 7,939,502. If the patent is for a software-related invention, the claims might include specific methods, systems, or computer-readable media that embody the invention.

Claim 1: A method for [brief description of the method], comprising:
  - Step 1: [Detailed description of the first step].
  - Step 2: [Detailed description of the second step].
  - Step 3: [Detailed description of the third step].

Claim 2: The method of claim 1, wherein [additional limitation or feature].

Patent Landscape and Related Patents

Understanding the patent landscape involves looking at other patents in the same field and how they relate to the current patent.

Global Dossier and Patent Families

Tools like the Global Dossier provided by the USPTO can help in identifying related patent applications filed in different jurisdictions, which can give a broader view of the patent family and its global reach[4].

Prior Art and Cited References

The patent will typically list prior art and cited references that were considered during the examination process. Analyzing these references can provide insights into the state of the art at the time of the invention.

Impact of Patent Litigation on Patent Quality

Patent litigation can significantly impact the quality of patents. For instance, the USPTO has taken steps to improve patent quality based on trends observed in patent litigation.

GAO Recommendations

A study by the Government Accountability Office (GAO) recommended that the USPTO should examine trends in patent infringement litigation and link this information to internal data on the patent examination process to improve patent quality[1].

Costs and Commercialization

The process of obtaining and maintaining a patent is costly and involves several stages.

Filing and Prosecution Costs

The costs of drafting and filing a patent application, as well as the subsequent prosecution process, can range from $8,000 to $20,000 for a U.S. utility patent, and significantly more for international patents[2].

Commercialization Strategies

Decisions on whether to pursue patent protection are often based on the commercial potential of the invention. Commercial partners may cover the costs of patenting if there is a reasonable likelihood of recovering these costs[2].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which must be clear, definite, and novel.
  • Detailed Description: A detailed description of the invention is crucial for understanding its components and functions.
  • Patent Landscape: Analyzing related patents and prior art helps in understanding the broader patent landscape.
  • Costs and Commercialization: The process of obtaining and maintaining a patent is costly and requires careful commercialization strategies.
  • Impact of Litigation: Patent litigation trends can influence patent quality and the examination process.

FAQs

Q: What is the primary purpose of the claims section in a patent?

A: The primary purpose of the claims section is to define the scope of the invention and specify what is protected by the patent.

Q: How does the USPTO use information from patent litigation to improve patent quality?

A: The USPTO can link information from patent litigation to its internal data on the patent examination process to identify patterns and improve the quality of issued patents[1].

Q: What is the Global Dossier, and how does it help in patent searches?

A: The Global Dossier is a service provided by the USPTO that allows users to access file histories of related patent applications from participating IP offices, helping in identifying patent families and their global reach[4].

Q: What are the typical costs associated with filing and prosecuting a U.S. utility patent?

A: The costs can range from $8,000 to $20,000, and additional costs are incurred during the patent prosecution process and after the patent is issued[2].

Q: Why is it important to consider commercial potential when deciding to file a patent application?

A: Considering commercial potential helps in determining whether the costs of patenting can be recovered and whether other forms of intellectual property protection might be more suitable[2].

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation, GAO-13-465.
  2. KU Office of Research: Intellectual Property Protection.
  3. USPTO: Patent Claims Research Dataset.
  4. USPTO: Search for patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,939,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,939,502

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
01116071Jul 02, 2001

International Family Members for US Patent 7,939,502

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1273292 ⤷  Subscribe C01273292/01 Switzerland ⤷  Subscribe
Austria 267591 ⤷  Subscribe
Australia 2002319226 ⤷  Subscribe
Bulgaria 108475 ⤷  Subscribe
Bulgaria 66328 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.